MAXIMIZING ONCOLOGY INVESTIGATE WITH INTEGRATED KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

during the fast evolving industry of oncology analysis, exact and productive mutation screening is essential for acquiring focused therapies. The KRAS providers System performs a pivotal function With this landscape by featuring complete options for KRAS mutation profiling and analysis. KRAS mutations, present in somewhere around 95% of RAS-associa